Table 4 Correlation between HNPs and HRCT findings in patients with anti-ARS antibody positive myositis-associated ILD
HNPs in plasma | HNPs in BALF | |||||||
|---|---|---|---|---|---|---|---|---|
N | r | 95% CI | q-value | N | r | 95% CI | q-value | |
HRCT findings | ||||||||
Ground glass opacity (%) | 30 | 0.328 | −0.037–0.616 | 0.49 | 27 | 0.085 | −0.305–0.451 | 0.80 |
Consolidation (%) | 30 | 0.031 | −0.333–0.387 | 1.00 | 27 | −0.452 | −0.710−− 0.087 | 0.08 |
Reticular opacities (%) | 30 | −0.089 | −0.435–0.280 | 1.00 | 27 | 0.465 | 0.103–0.718 | 0.09 |